Artificial womb could improve survival among premature babies

Researchers have designed a womb-like device that could allow premature babies to develop their lungs and organs in the critical few weeks that remain before they face the outside world.

In animal studies, the artificial womb provided a prenatal, fluid-filled environment in which premature lambs stayed alive and grew for four weeks, which is the longest time to date.

Leader of the research and fetal surgeon at Children’s Hospital of Philadelphia (CHOP), Alan Flake, says the lambs “appear to have normal development in all respects.”

The lambs could breathe normally, open their eyes, swallow and had normal neurological function and organ maturity, important improvement over the incubation and ventilating devices currently used to help keep babies alive.

Flake and team hope the technology could one day be used to treat tiny, premature human babies and help them to grow up healthy.

Advances in neonatal care have increased the survival of premature babies, but those pushing the limits of viability (22 to 23 weeks of gestation) only have a 30 to 50% chance of survival. Those that do survive are at a 90% risk of morbidity and severe illnesses such as lung disease, cerebral palsy and complications caused by underdeveloped organs.

As reported in Nature Communications, Flake and team tested the device using eight fetal lambs, which have very similar prenatal lung development to humans. The lambs were physiologically equivalent to human babies of 23- to 24-week gestation.

The device provides a fluid-filled, temperature-controlled, near-sterile environment in which a baby can breathe amniotic fluid as it would do in a real womb, whilst the heart pumps blood through the umbilical cord to a machine that adds oxygen and removes carbon dioxide.

Designer of the flow apparatus, Marcus Davey (also from CHOP) explains: “Fetal lungs are designed to function in fluid, and we simulate that environment here, allowing the lungs and other organs to develop, while supplying nutrients and growth factors."

The goal is to see the babies through from 23 weeks of gestation to 28 weeks, when the lungs are mature enough for the baby to breathe air and the most severe health outcomes are no longer likely.

Flake and team will continue to refine and safety-test the device, which will need to pass through animal trials before humans studies could be considered. It will also need to be down-sized, since human babies are only one-third the size of the lambs used in the study. The researchers believe the technology could be ready for such tests within five years.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 24). Artificial womb could improve survival among premature babies. News-Medical. Retrieved on October 10, 2024 from https://www.news-medical.net/news/20170426/Artificial-womb-could-improve-survival-among-premature-babies.aspx.

  • MLA

    Robertson, Sally. "Artificial womb could improve survival among premature babies". News-Medical. 10 October 2024. <https://www.news-medical.net/news/20170426/Artificial-womb-could-improve-survival-among-premature-babies.aspx>.

  • Chicago

    Robertson, Sally. "Artificial womb could improve survival among premature babies". News-Medical. https://www.news-medical.net/news/20170426/Artificial-womb-could-improve-survival-among-premature-babies.aspx. (accessed October 10, 2024).

  • Harvard

    Robertson, Sally. 2019. Artificial womb could improve survival among premature babies. News-Medical, viewed 10 October 2024, https://www.news-medical.net/news/20170426/Artificial-womb-could-improve-survival-among-premature-babies.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypes